BIORESTORATIVE THERAPIES INC. - COMMON STOCK

BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease

18 4 2022 08:00:00 提供 Nasdaq GlobeNewswire

BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification

04 4 2022 08:00:02 提供 Nasdaq GlobeNewswire

BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program

10 3 2022 08:00:01 提供 Nasdaq GlobeNewswire

BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program

16 2 2022 08:30:00 提供 Nasdaq GlobeNewswire

BioRestorative Therapies Announces it has Initiated its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease – Site Selection Underway

07 2 2022 09:00:00 提供 Nasdaq GlobeNewswire

BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell

07 2 2022 07:45:00 提供 Nasdaq GlobeNewswire

BioRestorative Therapies Announces Notice of Allowance for New Patent Application in Japan and Expansion of ThermoStem® IP Portfolio

02 2 2022 08:00:01 提供 Nasdaq GlobeNewswire